| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/08/2009 | EP2076248A2 Methods and compositions for controlling the bioavailability of poorly soluble drugs |
| 07/08/2009 | EP2076245A2 Lysine-based polymeric linkers |
| 07/08/2009 | EP2076241A2 Fibrous calcium pyrophosphate particles and methods of making and using same |
| 07/08/2009 | EP2076239A1 Combination therapy |
| 07/08/2009 | EP2076210A2 Medical device coatings and coated stents |
| 07/08/2009 | EP2076135A2 Novel crystal of (s)-(+)-2-(2-chlorophenyl)-2-hydroxy-ethyl carbamate |
| 07/08/2009 | EP2076132A1 P-toluene sulfonic acid salt of 5-amino-3-(2'-o-acetyl-3'-deoxy-beta -d-ribofuranosyl)-3h-thiazole [4, 5-d]pyrimidine-2-one and methods for preparation |
| 07/08/2009 | EP2076131A1 Process for preparing oxymorphone, naltrexone, and buprenorphine |
| 07/08/2009 | EP2076129A2 Novel curcumin and tetrahydrocurcumin derivatives |
| 07/08/2009 | EP2076128A2 Protein kinase inhibitors and methods for using thereof |
| 07/08/2009 | EP2076125A2 Tetra-o-substituted butane-bridge modified ndga derivatives, their synthesis and pharmaceutical use |
| 07/08/2009 | EP2076124A2 Styrenyl derivative compounds for treating ophthalmic diseases and disorders |
| 07/08/2009 | EP2076122A2 Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders |
| 07/08/2009 | EP2037762A4 Method to prepare pure curcumin |
| 07/08/2009 | EP1991241A4 Compositions and methods for the induction and maintenance of quality sleep |
| 07/08/2009 | EP1948661B1 Pyrazolo[4,3-d]pyrimidin-5-yl)derivative used as pde5 inhibitors |
| 07/08/2009 | EP1904511B1 Homogemcitabines |
| 07/08/2009 | EP1879573A4 Modulators of indoleamine 2,3-dioxygenase and methods of using the same |
| 07/08/2009 | EP1869038B1 Substituted 5,6,7,8-tetrahydro-imidazo[1,2-a]pyridin-2-ylamine compounds and their use for producing drugs |
| 07/08/2009 | EP1843767B1 2,5-disubstituted phenyl methanone derivatives as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders. |
| 07/08/2009 | EP1836173A4 Anti-inflammatory medicaments |
| 07/08/2009 | EP1776103B1 Ruthenium complexes for treating cancers |
| 07/08/2009 | EP1765785B1 Prostaglandin analogs |
| 07/08/2009 | EP1765352A4 Antagonizing an adenosine a2a receptor to amelioriate one or more components of addictive behavior |
| 07/08/2009 | EP1753744B1 Prodrugs of pyrrolylpyrimidine erk protein kinase inhibitors |
| 07/08/2009 | EP1735002B1 Cancer therapy comprising a nuclear receptor ligand and a hdac inhibitor |
| 07/08/2009 | EP1685118B1 Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 07/08/2009 | EP1664016B9 Therapeutic agents useful for treating pain |
| 07/08/2009 | EP1660103A4 Enhancement of magnesium uptake in mammals |
| 07/08/2009 | EP1660048A4 Method for deterring abuse of opioids by combination with non-release formulation of emetic |
| 07/08/2009 | EP1635821B1 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (phenyl)amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases |
| 07/08/2009 | EP1626970B1 Azabicycloalkane compounds as muscarinic receptor antagonists |
| 07/08/2009 | EP1622926B1 Novel method and intermediates for the preparation of 19-nor-steroids-17-halogen compounds |
| 07/08/2009 | EP1592686B1 Gyrase inhibitors and uses thereof |
| 07/08/2009 | EP1539933A4 Methods of organ regeneration |
| 07/08/2009 | EP1536768B1 Biodegradable composition with prolonged release of an antitumour agent and preparation thereof |
| 07/08/2009 | EP1511740B1 Phenyl-thiophene type vitamin d receptor modulators |
| 07/08/2009 | EP1511508A4 Method of treating dyslipidemic disorders |
| 07/08/2009 | EP1495022B1 Diazabicyclo alkane derivatives with nk1 antagonistic activity |
| 07/08/2009 | EP1440962B1 Stabilized compositions of aqueous reduced coenzyme q solution |
| 07/08/2009 | EP1435918B1 Highly compressible ethylcellulose for tableting |
| 07/08/2009 | EP1401808B1 Gpe analogs and peptidomimetics |
| 07/08/2009 | EP1126826B9 Multiparticulate modified release composition of methylphenidate |
| 07/08/2009 | EP1073647B1 12,13-cyclopropane epothilone derivatives |
| 07/08/2009 | EP0819000B1 Nodulisporic acid derivatives |
| 07/08/2009 | EP0738142B1 Perfluorocarbons as anti-inflammatory agents |
| 07/08/2009 | CN101479238A Amine derivative having npyy5 receptor antagonist activity |
| 07/08/2009 | CN101478976A Polymers with antimicrobial activity containing quaternary ammonium groups |
| 07/08/2009 | CN101478975A Tooth enamel dissolution inhibitor |
| 07/08/2009 | CN101478974A Methods and compositions for inducing torpor in a subject |
| 07/08/2009 | CN101478973A Novel silicone film former for delivery of actives |
| 07/08/2009 | CN101478972A Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith |
| 07/08/2009 | CN101478971A Implants for the treatment of dopamine associated states |
| 07/08/2009 | CN101478970A Quinoxalinyl macrocyclic hepatitis C virus serine protease inhibitors |
| 07/08/2009 | CN101478969A Use of PKC inhibitors in diabetic complications |
| 07/08/2009 | CN101478968A Camptothecin-analog with a novel, flipped lactone-stable, E-ring and methods for making and using same |
| 07/08/2009 | CN101478967A Phenol derivatives for the treatment of respiratory diseases |
| 07/08/2009 | CN101478966A Compressed preparation |
| 07/08/2009 | CN101478965A High dose oral pharmaceutical compositions of artemether and lumefantrine |
| 07/08/2009 | CN101478964A Compositions of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 07/08/2009 | CN101478963A Methods and compositions for producing anti-androgenic effects |
| 07/08/2009 | CN101478962A New CXCR2 inhibitors |
| 07/08/2009 | CN101478961A S1P receptor modulators for treating multiple sclerosis |
| 07/08/2009 | CN101478960A Compounds a-r-x for the manufacture of pharmaceutical preparations |
| 07/08/2009 | CN101478959A Organic compounds |
| 07/08/2009 | CN101475526A Carboxylic acid derivatives inhibiting the binding of integrins to receptors thereof |
| 07/08/2009 | CN101475524A Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation |
| 07/08/2009 | CN101474198A Application of MEK1 protein blocking agent in preparing antiviral medicine |
| 07/08/2009 | CN101474197A Application of coumpound baicalin-zinc in preparing medicament for resisting peptic ulcer |
| 07/08/2009 | CN101474196A Flavone active site of Vernonia cinerea as well as preparation method and use thereof |
| 07/08/2009 | CN101474195A Medicament composition for treating cardiac and cerebral vascular disease |
| 07/08/2009 | CN101474194A Application of ginseng saponin IH901 in preparing sensitizing and potentiating agent of medicament for resisting liver cancer |
| 07/08/2009 | CN101474193A Application of ginseng saponin IH901 in preparing angiogenesis inhibitor |
| 07/08/2009 | CN101474192A Veramyst medicinal preparation and preparation method |
| 07/08/2009 | CN101474191A Pharmaceutical composition for treating asthma and chronic obstructive pulmonary disease |
| 07/08/2009 | CN101474190A Uses of stigmastane-3,5,6-triol and derivatives thereof for preparing antiviral medicine, and novel stigmastane-3,5,6-triol derivates |
| 07/08/2009 | CN101474189A Halometasone medicinal preparation and preparation method |
| 07/08/2009 | CN101474188A Miconazole nitrate emulsifiable paste and preparation method |
| 07/08/2009 | CN101474187A Preparation method of ofloxacin sustained-release capsules |
| 07/08/2009 | CN101474186A 2,3,4,7,8-polysubstituted naphthyridine [4,3-d] pyridine derivates with anti-tumor activity |
| 07/08/2009 | CN101474185A Western medicine compound preparation for resisting cardiovascular disease and preparation method thereof |
| 07/08/2009 | CN101474184A Hydroxycamptothecin-phospholipid complex as well as preparation method and use thereof |
| 07/08/2009 | CN101474183A Preparation method of targeting antineoplastic medicine nitidine chloride complexes, product thereof and injection containing the product |
| 07/08/2009 | CN101474182A Application of G1 in preparing medicament for resisting tumor, osteoporosis and senile dementia |
| 07/08/2009 | CN101474181A Application of corytuberine in preparing medicament for resisting Eimeria tenella |
| 07/08/2009 | CN101474180A Medicament composition containing levamlodipine beaylate and simvastatin |
| 07/08/2009 | CN101474179A Application of penehyclidine hydrochloride in preparing medicament for treating endotoxic shock |
| 07/08/2009 | CN101474178A Application of penehyclidine hydrochloride in preparing medicament for treating cardiogenic shock |
| 07/08/2009 | CN101474177A Nimodipine solid dispersoid and preparation method thereof |
| 07/08/2009 | CN101474176A Pharmaceutical composition of flucloxacillin sodium and amoxicillin sodium and production method thereof |
| 07/08/2009 | CN101474175A Oral solid preparation of Febuxostat with high-bioavailability and preparation method thereof |
| 07/08/2009 | CN101474174A Application of N-[2-methyl-1-(pyrrolidine-1-carbonyl)-propyl]-3-phenyl propionamide in pharmacy |
| 07/08/2009 | CN101474173A Application of cumarin coumpound Murraya jasminorage ketone in preparing anti-tumor medicament |
| 07/08/2009 | CN101474172A Pharmacy use of oxyethyl group substituted silybin for inhibiting herpes simplex virus |
| 07/08/2009 | CN101474171A Oral solid preparation of escitalopram oxalate and preparation method thereof |
| 07/08/2009 | CN101474170A Application of isosulfocyanate compound in preparing medicament for treating leukemia |
| 07/08/2009 | CN100509858C Cross-linked polysaccharide composition |
| 07/08/2009 | CN100509843C Acid-modified arabinogalactan protein composition |
| 07/08/2009 | CN100509833C Macrolides with antibacterial activity |
| 07/08/2009 | CN100509819C Crystal of oxacephem |